How do single-use biopsy devices compare economically to reusable systems in high-volume settings?

Single-use devices eliminate reprocessing labor and sterilization costs, averaging USD 12–18 per cycle. In facilities performing over 500 annual procedures, total cost of ownership for single-use models is roughly equivalent to reusable platforms within three years [14]. Read More

What reimbursement changes are most likely to shift biopsy procedure volumes before 2030?

Medicare's 2024 ASC-approved CPT code expansion is the most consequential near-term catalyst. Commercial payors in the U.S. and private insurers in Germany are mirroring these codes, accelerating outpatient biopsy migration [12]. Read More

How are MRI-fusion platforms changing prostate biopsy accuracy rates?

MRI-fusion targeted biopsy detects clinically significant prostate cancer at rates 20–30% higher than systematic TRUS-guided sampling. This accuracy improvement reduces unnecessary repeat procedures and supports higher per-case device utilization [3]. Read More

What role does specimen adequacy verification play in device purchasing decisions?

Real-time specimen verification reduces non-diagnostic rates from 8–12% to under 3%. Hospital procurement committees increasingly mandate this feature, favoring platforms from Hologic and BD that integrate verification imaging [4]. Read More

How are biopsy device manufacturers addressing sustainability concerns?

Leading firms are developing bio-polymer needle housings and recyclable packaging to comply with the EU Waste Framework Directive. BD and Hologic have both announced carbon-neutral single-use product targets for 2030 [14]. Read More

What training barriers limit adoption of AI-guided biopsy systems in community hospitals?

AI-guided platforms require 15–25 supervised cases for operator proficiency certification. Manufacturers are addressing this through simulation-based training modules that compress the learning curve to under one week [15]. Read More

How does the Biopsy Devices Market outlook differ for bone-marrow versus soft-tissue applications?

Bone-marrow biopsy devices grow at a slower 3.1% CAGR due to stable hematologic-procedure volumes. Soft-tissue applications benefit from expanding solid-tumor screening programs and drive the majority of forecast growth [1]. Read More

Biopsy Devices Market (2025 - 2035)

ID: MRFR/MED/1652-CR

80 Pages

Satyendra Maurya

Last Updated: June 30, 2026

Biopsy Devices Market Research Report: Size, Share, Trend Analysis By Product Type (Biopsy Guns, Biopsy Guidance System, Biopsy Needles [Vacuum-Assisted Biopsy (VAB) Devices, Fine Needle Aspiration Biopsy (FNAB) Devices, Core Needle Biopsy (CNB) Devices], Biopsy Forceps, Localization Wires, and Others), By Applications (Breast Biopsy, Prostate Biopsy, Liver Biopsy, Lung Biopsy, Gynecological Biopsy, and Others), By Guidance Technique (Ultrasound-Guided Biopsy, Stereotactic Guided Biopsy, MRI-Guided Biopsy, CT Guided Biopsy, and Others), By End Users (Hospitals & Clinics, Diagnostic & Imaging Centers, Academic & Research Institutes and Others), By Region (North America, Europe, Asia-Pacific, And Rest Of The World)) - Growth Outlook & Industry Forecast Till 2035

Biopsy Devices Market

Market Size

Forecast Period2025-2035

CAGR (2025-2035)4.30%

2025 Market SizeUSD 2.40 Billion

2035 Market SizeUSD 3.65 Billion

Key Players

Hologic Inc.

Medtronic plc

Merit Medical Systems

Boston Scientific Corporation

Cardinal Health

Cook Medical

Trends

Rising Global Cancer Incidence
Government-Funded Screening Mandates
AI-Integrated Image-Guidance Platforms

Opportunities

AI-Powered Robotic Biopsy Platforms
Emerging-Market Hospital Infrastructure Buildout
Digital Pathology Data Monetization

Summary Table of Contents Segmentation Methodology Download PDF

1 Market Overview |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Market Summary & Key Takeaways
3 Market Dynamics |
1. 3.1 Market Drivers Analysis | |
  1. 3.1.1 Rising Global Cancer Incidence | |
  2. 3.1.2 Government-Funded Screening Mandates | |
  3. 3.1.3 AI-Integrated Image-Guidance Platforms | |
  4. 3.1.4 Shift to Minimally Invasive Workflows | |
  5. 3.1.5 Ambulatory Surgical Center Expansion | |
  6. 3.1.6 Aging Population Demographics | |
  7. 3.1.7 Single-Use Sterile Device Preference |
2. 3.2 Market Restraints Analysis | |
  1. 3.2.1 Liquid-Biopsy Competitive Substitution | |
  2. 3.2.2 Product Sterility Recalls and Regulatory Scrutiny | |
  3. 3.2.3 High Capital Cost of Advanced Systems | |
  4. 3.2.4 Shortage of Trained Interventional Radiologists | |
  5. 3.2.5 Reimbursement Variability Across Jurisdictions |
3. 3.3 Market Opportunity Analysis | |
  1. 3.3.1 AI-Powered Robotic Biopsy Platforms | |
  2. 3.3.2 Emerging-Market Hospital Infrastructure Buildout | |
  3. 3.3.3 Digital Pathology Data Monetization | |
  4. 3.3.4 Single-Use Disposable Device Models | |
  5. 3.3.5 Point-of-Care Rapid Tissue Analysis |
4. 3.4 Industry Value Chain Analysis |
5. 3.5 Porter's Five Forces Analysis
4 Global Biopsy Devices Market Size & Forecast (2021–2035) |
1. 4.1 Historical Market Size (2021–2025) |
2. 4.2 Current & Forecast Market Size (2026–2035) |
3. 4.3 Market Size by Revenue (USD Billion) |
4. 4.4 Year-over-Year Growth Analysis
5 Segmentation Analysis |
1. 5.1 By Product Type | |
  1. 5.1.1 Needle-Based Biopsy Instruments (Core Biopsy Devices, and More) | |
  2. 5.1.2 Procedure Trays | |
  3. 5.1.3 Others |
2. 5.2 By Application | |
  1. 5.2.1 Breast Biopsy | |
  2. 5.2.2 Lung Biopsy | |
  3. 5.2.3 Colorectal Biopsy | |
  4. 5.2.4 Prostate Biopsy | |
  5. 5.2.5 Others |
3. 5.3 By End User | |
  1. 5.3.1 Hospitals | |
  2. 5.3.2 Diagnostic & Imaging Centers | |
  3. 5.3.3 Others (ASCs, Research Labs)
6 Regional Analysis |
1. 6.1 North America | |
  1. 6.1.1 United States | |
  2. 6.1.2 Canada | |
  3. 6.1.3 Mexico |
2. 6.2 Europe | |
  1. 6.2.1 Germany | |
  2. 6.2.2 United Kingdom | |
  3. 6.2.3 France | |
  4. 6.2.4 Italy | |
  5. 6.2.5 Spain | |
  6. 6.2.6 Nordic Countries | |
  7. 6.2.7 Russia | |
  8. 6.2.8 Rest of Europe |
3. 6.3 Asia-Pacific | |
  1. 6.3.1 China | |
  2. 6.3.2 India | |
  3. 6.3.3 Japan | |
  4. 6.3.4 South Korea | |
  5. 6.3.5 ASEAN | |
  6. 6.3.6 Rest of Asia-Pacific |
4. 6.4 South America | |
  1. 6.4.1 Brazil | |
  2. 6.4.2 Argentina | |
  3. 6.4.3 Rest of South America |
5. 6.5 Middle East & Africa | |
  1. 6.5.1 Saudi Arabia | |
  2. 6.5.2 UAE | |
  3. 6.5.3 South Africa | |
  4. 6.5.4 Egypt | |
  5. 6.5.5 Rest of MEA
7 Competitive Landscape |
1. 7.1 Market Share Analysis (2025) |
2. 7.2 Competitive Benchmarking Matrix |
3. 7.3 Company Profiles | |
  1. 7.3.1 Becton, Dickinson and Company (BD) | |
  2. 7.3.2 Hologic Inc. | |
  3. 7.3.3 Medtronic plc | |
  4. 7.3.4 Merit Medical Systems | |
  5. 7.3.5 Boston Scientific Corporation | |
  6. 7.3.6 Cardinal Health | |
  7. 7.3.7 Cook Medical | |
  8. 7.3.8 Argon Medical Devices | |
  9. 7.3.9 Stryker Corporation | |
  10. 7.3.10 Leica Biosystems (Danaher)
8 Future Outlook & Strategic Recommendations (2026–2035) |
1. 8.1 AI-Guided Precision Biopsy and Autonomous Navigation |
2. 8.2 Convergence of Liquid and Tissue Biopsy Workflows |
3. 8.3 Decentralized Cancer Screening in LMICs |
4. 8.4 Next-Generation Single-Use and Sustainable Device Platforms
9 Recent Developments & News
10 Frequently Asked Questions (FAQs)
11 Report Scope & Methodology |
1. 11.1 Study Period & Base Year |
2. 11.2 Data Sources & Citations |
3. 11.3 Abbreviations
1 LIST OF TABLES |
TABLE 1 Global Biopsy Devices Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
TABLE 2 Global Biopsy Devices Market – Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Global Biopsy Devices Market – Driver Impact Analysis |
TABLE 4 Global Biopsy Devices Market – Restraint Impact Analysis |
TABLE 5 Global Biopsy Devices Market Size, by Product Type, 2021–2035 (USD Billion) |
TABLE 6 Global Biopsy Devices Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 7 Global Biopsy Devices Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 8 Global Biopsy Devices Market Size, by Region, 2021–2035 (USD Billion) |
TABLE 9 North America Biopsy Devices Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 10 Europe Biopsy Devices Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 11 Asia-Pacific Biopsy Devices Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 12 South America Biopsy Devices Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 13 Middle East & Africa Biopsy Devices Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 14 North America Biopsy Devices Market Size, by Product Type, 2021–2035 (USD Billion) |
TABLE 15 North America Biopsy Devices Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 16 North America Biopsy Devices Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 17 Europe Biopsy Devices Market Size, by Product Type, 2021–2035 (USD Billion) |
TABLE 18 Europe Biopsy Devices Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 19 Europe Biopsy Devices Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 20 Asia-Pacific Biopsy Devices Market Size, by Product Type, 2021–2035 (USD Billion) |
TABLE 21 Asia-Pacific Biopsy Devices Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 22 Asia-Pacific Biopsy Devices Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 23 South America Biopsy Devices Market Size, by Product Type, 2021–2035 (USD Billion) |
TABLE 24 South America Biopsy Devices Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 25 South America Biopsy Devices Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 26 Middle East & Africa Biopsy Devices Market Size, by Product Type, 2021–2035 (USD Billion) |
TABLE 27 Middle East & Africa Biopsy Devices Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 28 Middle East & Africa Biopsy Devices Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 29 Competitive Benchmarking Matrix – Global Biopsy Devices Market, 2025 |
TABLE 30 Company Profiles – Key Players, Global Biopsy Devices Market |
TABLE 31 Recent Developments & Strategic Announcements, 2023–2025 |
TABLE 32 Report Scope & Methodology |
TABLE 33 Detailed Sources and Citations
2 LIST OF FIGURES |
FIGURE 1 Global Biopsy Devices Market Dynamics (Drivers, Restraints, Opportunities) |
FIGURE 2 Industry Value Chain Analysis – Biopsy Devices Market |
FIGURE 3 Porter's Five Forces Analysis – Global Biopsy Devices Market |
FIGURE 4 Global Biopsy Devices Market Size Trend & Forecast (USD Billion), 2021–2035 |
FIGURE 5 Global Biopsy Devices Market Share, by Product Type (%), 2025 |
FIGURE 6 Global Biopsy Devices Market Share, by Application (%), 2025 |
FIGURE 7 Global Biopsy Devices Market Share, by End User (%), 2025 |
FIGURE 8 Global Biopsy Devices Market Share, by Region (%), 2025 |
FIGURE 9 North America Biopsy Devices Market Share, by Country (%), 2025 |
FIGURE 10 Europe Biopsy Devices Market Share, by Country (%), 2025 |
FIGURE 11 Asia-Pacific Biopsy Devices Market Share, by Country (%), 2025 |
FIGURE 12 South America Biopsy Devices Market Share, by Country (%), 2025 |
FIGURE 13 Middle East & Africa Biopsy Devices Market Share, by Country (%), 2025 |
FIGURE 14 Competitive Landscape – Global Biopsy Devices Market Revenue Share (%), 2025

Certified Researchers

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
By Product Type	Needle-Based Biopsy Instruments, Procedure Trays, Others	Needle-Based Biopsy Instruments	Procedure Trays
By Application	Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, Others	Breast Biopsy	Lung Biopsy
By End User	Hospitals, Diagnostic & Imaging Centers, Others (ASCs, Research Labs)	Hospitals	Others (ASCs, Research Labs)
By Region	North America, Europe, Asia-Pacific, South America, Middle East & Africa	North America	Asia-Pacific

Market Segmentation Overview

By Product Type

Sub-Segment	Key Trend
Needle-Based Biopsy Instruments (Core Biopsy Devices, and More)	Transition from manual to automated spring-loaded and vacuum-assisted platforms
Procedure Trays	Growth in pre-assembled sterile kits to reduce setup variability and infection risk
Others	Specialty instruments for emerging applications including pediatric and bone-marrow biopsy

Needle-based instruments continue to anchor the product landscape, with automated core devices representing the highest unit volume and vacuum-assisted systems capturing premium ASP tiers in breast-biopsy suites. Procedure trays are gaining traction as hospitals standardize kit configurations to streamline perioperative workflows and reduce per-procedure preparation time.

By Application

Sub-Segment	Key Trend
Breast Biopsy	Mammography recall pathways and vacuum-assisted sampling drive consistent volumes
Lung Biopsy	LDCT screening program rollout accelerates follow-up tissue-sampling demand
Colorectal Biopsy	Rising colonoscopy compliance rates increase polypectomy and biopsy throughput
Prostate Biopsy	MRI-fusion navigation displacing TRUS-guided systematic sampling
Others	Thyroid fine-needle aspiration and kidney core biopsy gaining clinical priority

Breast biopsy represents the most established application segment, supported by multi-decade screening infrastructure across North America and Europe. Lung biopsy is the breakout growth category, underpinned by the expansion of LDCT screening eligibility in the United States, Australia, and select European markets.

By End User

Sub-Segment	Key Trend
Hospitals	Concentration of complex image-guided procedures requiring MRI/CT suites
Diagnostic & Imaging Centers	Outpatient referral growth for ultrasound-guided breast and thyroid biopsy
Others (ASCs, Research Labs)	ASC channel expansion following Medicare reimbursement code alignment

Hospitals remain the dominant procedural venue due to their investment in capital-intensive imaging platforms. Ambulatory surgical centers are the fastest-growing channel, benefiting from payor-driven incentives to shift straightforward biopsy procedures to lower-cost outpatient environments.

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”